Thursday morning, the Senate Medical Affairs Committee voted unanimously to move “Right to Try” legislation forward.

There is a way to provide terminally ill South Carolinians with the safe, FDA approved drugs they need.

Right to Try: Access to experimental drugs for the terminally ill is goal of bill by Senator Campbell.

Medicaid expansion, particularly in South Carolina and other states that have opted against broadening the federal health insurance program, is shaping up to be a hot-button topic.

That is why the Right-to-Try movement is so important. For every person who lives thanks to alternatives found elsewhere, there are tens of thousands of others who can’t afford to seek experimental treatment. That’s not fair to the poor, to the disadvantaged or to anyone who just wants a chance. We all should have the freedom to try new treatments that may work.

Is Obamacare here to stay? That’s what it’s proponents would have you believe. But as too many American’s are learning firsthand, it’s still unworkable, unpopular and unaffordable.

“But there is opportunity here. Though this is the end of a single legal battle, Palmetto Promise Institute and freedom-loving people all over America will continue this fight in the Congress..."

If King v. Burwell provides them with the opportunity, Congress should heed the overwhelming desire of the American people and create a system that makes healthcare accessible and affordable for each individual American.

Today, Palmetto Promise Institute commended 43 members of the South Carolina House of Representatives for stating that they do not intend to create a state exchange should the U.S. Supreme Court overturns subsidies in the federal healthcare exchange in King v. Burwell court case currently pending before the Court. A Court ruling is expected mid-June.

Patients and taxpayers in our states are at the mercy of Congressional action to rein in abuse of 340B and restore the program’s original intent. Despite Congress’ long to-do list, this is one that should be a no-brainer. The time to act is now.